CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IS Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IS Pharma Ltd
Office Village
Chester Business Park
Phone: +44 1244625150p:+44 1244625150 chester, WAL  CH4 9QZ  United Kingdom Fax: +44 1244625151f:+44 1244625151
Business Summary
IS Pharma Plc is a United Kingdom-based holding company. The Company’s subsidiaries, IS Pharmaceuticals Limited and Acorus Therapeutics Limited, are engaged in the development and commercial exploitation of healthcare products and related activities. Its products include Aloxi, Aquoral ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The Company also focuses on late-stage pharmaceuticals and medical devices, which includes oncology, critical care and neurology. As of March 31, 2010, the Company’s wholly owned subsidiaries include IS Pharmaceuticals Limited, Speciality European Pharma International AG, Maelor Laboratories Limited and Acorus Therapeutics Limited. In September 2010, the Company announced the launch of Aquoral, an oral spray, indicated for the lubrication and protection of the oral mucosa in xerostomia (dry mouth) in the United Kingdom.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20103/31/2010Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
9999 Non-classified establishments
3842 Orthopedic, prosthetic, and surgical appliances and supplies
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board H.GeoffMcMillan 1/20/2006 5/1/2005
Chief Executive Officer, Executive Director TimothyWright 10/17/2005 9/1/2005
Chief Financial Officer,Company Secretary, Executive Director Frank M.Hall 48 1/12/2009 1/12/2009
Non-Executive Director John H.Gregory 62 6/27/2000 6/27/2000
Non-Executive Director MichaelMcDonald 56 5/6/2009 5/6/2009

Business Names
Business Name
Acorus Therapeutics Ltd
IS Pharma Plc
IS Pharmaceuticals Limited
5 additional Business Names available in full report.

General Information
Number of Employees: 21 (As of 3/31/2010)
Outstanding Shares: 52,045,066 (As of 5/10/2011)
Shareholders: 1,562
Stock Exchange: SEA
Fax Number: +44 1244625151


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023